Development and validation of a risk prediction model for short-term progression of carotid atherosclerosis among early middle age adults

2024-10-1

Macrophages regulate plaque progression in diabetic Apoe mice dependent on Pi4p/Nlrp3 signaling pathway

2024-10-1

Low-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida

2024-10-1

CRISPR/Cas9-mediated suppression of A4GALT rescues endothelial cell dysfunction in a Fabry disease vasculopathy model derived from human induced pluripotent stem cells

2024-10-1

Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical review

2024-10-1

Cardiovascular risk in ANCA-associated vasculitis: monocyte phenotyping reveals distinctive signatures between serological subsets

2024-10-1

Genetic evidence for lifestyle and cardiometabolic factors on the risk of aortic aneurysms: a comprehensive Mendelian randomization study

2024-10-1

Tobacco smoking is associated with sex- and plaque-type specific upregulation of CRLF1 in atherosclerotic lesions

2024-10-1

Differences in HDL-related coronary heart disease risk between individuals with and without diabetes

2024-10-1

HDL cholesterol efflux capacity and cholesterol loading capacity in long-term fasting: Evidence from a prospective, single-arm interventional study in healthy individuals

2024-10-1

In Memoriam: Akira Endo (1933-2024)

2024-9-13

Recurrent cardiovascular and limb events in 294,428 patients with Coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: The RESRISK cohort study

2024-9-1

Metabolites derived from radical oxidation of PUFA: NEO-PUFAs, promising molecules for health?

2024-9-1

The aortic valve as a window to dementia

2024-9-1

Genetic and epigenetic regulation of inflammasomes: role in atherosclerosis

2024-9-1

The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction

2024-9-1

The singular French PCSK9-p.Ser127Arg gain-of-function variant: a significant player in cholesterol levels from a 775-year-old common ancestor

2024-9-1

Is colchicine on its way to a place in the polypill for cardiovascular prevention?

2024-9-1

Editorial Board

2024-9-1

Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials

2024-9-1

Nucleic acid liquid biopsies in cardiovascular disease: Cell-free DNA liquid biopsies in cardiovascular disease

2024-9-1

Nucleic acid liquid biopsies in cardiovascular disease: Cell-free RNA liquid biopsies in cardiovascular disease

2024-9-1

Age-related annual changes in arterial stiffness in healthy adults: Insights from a Large Korean Cohort Study

2024-9-1

Vascular disease and ischemic stroke in patients with atrial fibrillation: Temporal trends and age-related differences

2024-9-1

Local vascular Klotho mediates diabetes-induced atherosclerosis via ERK1/2 and PI3-kinase-dependent signaling pathways.

2024-9-1

Endothelial epoxyeicosatrienoic acid release is intact in aldosterone excess

2024-9-1

Arterial inflammation on [18F]FDG PET/CT in melanoma patients treated with and without immune checkpoint inhibitors: CHECK-FLAME I

2024-9-1

Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults- results from a large population-based study.

2024-9-1

Progression of coronary artery calcium density and major adverse cardiovascular events

2024-9-1

Silencing ARL11 relieved atherosclerotic inflammation and lipid deposition via retraining JAK2/STAT1 pathway

2024-9-1

Rising to the Challenge of Cardio-Renal-Metabolic Disease in the 21st Century Translating evidence into best clinical practice to prevent and manage atherosclerosis

2024-9-1

MiR-1290 induces endothelial-to-mesenchymal transition and promotes vascular restenosis after angioplasty by targeting FGF2

2024-9-1

Enhancement of high-density lipoprotein-associated protease inhibitor activity prevents atherosclerosis progression

2024-9-1

Very short-term effects of a single dose of a proprotein convertase subtilisin/kexin 9 inhibitor before percutaneous coronary intervention: A single-arm Study

2024-9-1

HDL, reverse cholesterol transport, and atherosclerosis: Unravelling the complexity or adding to the confusion?

2024-8-9

Lipids associated with atherosclerotic plaque instability revealed by mass spectrometry imaging of human carotid arteries

2024-8-8

Peripheral artery disease and risk of kidney outcomes: The Atherosclerosis Risk in Communities (ARIC) study

2024-8-8

Rare variants in U2-spliceosome genes are involved in autosomal dominant hypercholesterolemia

2024-8-1

Features of atherogenity markers - Lipoprotein (a) and non-HDL-cholesterol - In rroman population

2024-8-1

Phospholipid-derived lysophospholipids in (patho)physiology

2024-8-1

Rabies vaccine induced microangiopathy

2024-8-1

Development of APOC3 antisense oligonucleotide for broader dyslipidemia

2024-8-1

Analysis of platelet hemostasis in patients on the background of dual antiplatelet therapy for 12 months

2024-8-1

Subclinical atherosclerosis in pseudo-hypertriglyceridemia resulting from hyperglycerolemia

2024-8-1

The dual role of adiposopathy in atherogenesis in low risk individuals

2024-8-1

The polycomb repressive complex 2 (PRC2) in macrophages and atherosclerosis

2024-8-1

Plasma carotenoids are independently associated with circulating granulocytes and systemic inflammatory markers in a Swedish middle-aged population

2024-8-1

Corrigendum to “Fibroblast growth factor 23 as a predictor of cardiovascular and all-cause mortality in prospective studies” [Atherosclerosis 261 (2017) 1–11]

2024-8-1

Breastfeeding and lipid profile and cardiovascular risk markers in women with familial hypercholesterolemia: The FH-femina study protocol

2024-8-1

Exploring baseline characteristics and achievement of low-density lipoprotein cholesterol targets in Greek children and adults with homozygous familial hypercholesterolemia: Key findings from the HELLAS-FH registry

2024-8-1